Introduction {#s1}
============

Hearing loss is the most common form of sensory impairment in humans, affecting over 7% of the world's population (466 million people) according to WHO ([@bib108]). This impairing disability is caused by genetic defects, environmental factors or a combination of both. Genetic hearing loss, including non-syndromic and syndromic deafness, is estimated to account for 50% of cases. Certain mutations can also cause susceptibility to noise-induced damage, presbycusis and other complex forms of hearing loss ([@bib90]).

Clinical heterogeneity reflects the rich cellular and molecular complexity of the cochlea. Indeed the development of the inner ear and the maintenance of hearing throughout life requires the precise spatial and temporal expression of a variety of genes, as well as the strict regulation of the interactome ([@bib30]; [@bib54]; [@bib90]). The phenotypic and genetic heterogeneity of hearing loss is still under study, and to this end animal studies and particularly mice model systems are fundamental tools ([@bib7]). Their characterization will help us to develop new therapeutic strategies and to understand the molecular relationship between environmental and genetic factors in the establishment of the different types of sensorineural hearing loss.

Age-related hearing loss (ARHL) is a form of progressive hearing loss and a degenerative process. ARHL arises due to impaired function and consequent cellular loss, both in the peripheral inner ear structures and in central elements of the auditory pathway ([@bib51]). It is thought to be multifactorial and the result of poorly understood genetic susceptibility and environmental factors, such as exposure to excessive noise, ototoxic chemicals, and medical conditions that exacerbate hearing loss in older people ([@bib41]).

Studies in humans and animal models, particularly mice, have pointed to oxidative stress and mitochondrial dysfunction as hallmarks of ageing in several tissues ([@bib55]), including the cochlea ([@bib66]; [@bib79]; [@bib99]).

Mitogen-activated protein kinases (MAPKs) are intracellular protein Ser/Thr kinases that, upon phosphorylation in response to extracellular stimuli, regulate cellular responses such as proliferation, differentiation, motility and survival. The classical MAPKs include ERK1/2/5, which induce tissue growth and survival, and the stress-activated protein kinases JNK1/2/3 and p38 isoforms (MAPK11/12/13/14), which are mediators of several stress stimuli ([@bib12]; [@bib29]; [@bib50]).

JNK and p38 MAPK transcripts and proteins are expressed in the cochlea from late intrauterine development ([@bib76]; [@bib83]). They form part of the adult cochlear response to noise insult ([@bib38]; [@bib56]) and to ageing ([@bib89]). In this connection, their chemical inhibition promotes the survival of cochlear cells after damage ([@bib93]; [@bib106]).

MAP kinase phosphatases (MKP) belong to the large family of dual-specificity phosphatases. These proteins contain a conserved kinase-interaction motif and specifically dephosphorylate the threonine and tyrosine residues of phosphorylated activated MAPKs, thereby controling the duration, magnitude and spatiotemporal profile of their activities ([@bib73]).

MKPs can be subdivided into three classes on the basis of their gene structure, sequence similarity and subcellular localization. The first is formed by inducible nuclear phosphatases and includes MKP1 (DUSP1), PAC1 (DUSP2), MKP2 (DUSP4) and HVH3 or DUSP5, which target all classic MAPK with different substrate affinities. The second class includes the cytoplasmic phosphatases MKP3 (DUSP6), MKPX (DUSP7) and MKP4 (DUSP9), which preferentially inactivate ERK1/ERK2. The third class comprises DUSP8, MKP5 (DUSP10) and MKP7 (DUSP16), which can be both nuclear and cytoplasmic and which target stress-activated MAPKs isoforms ([@bib73]). Among the first class, DUSP1 is an inducible and primarily nuclear phosphatase that is the principal regulator of the stress MAPKs ([@bib25]).

MKPs are involved in immune cell function, regulating the inflammatory responses both positively and negatively depending on the specific MKP ([@bib35]). Their dysregulation has also been associated with different types of cancer and pace of cancer progression ([@bib6]).

Here, we describe the auditory phenotype of the *Dusp1* null mouse. Our results show that: (i) DUSP1 is expressed in the mouse cochlea with a temporal age-regulated pattern; (ii) DUSP1 deficit leads to a premature onset of hearing loss and to an accelerated progression of the hearing-loss phenotype that is caused by the degeneration and death of the sensory epithelium and spiral ganglion neurons in the cochlea; and (iii) dysregulated oxidative balance and exacerbated inflammatory response are among the mechanisms underlying hearing loss in* Dusp1-*deficient mice.

Results {#s2}
=======

*Dusp1* is expressed and age-regulated in the mouse inner ear {#s2-1}
-------------------------------------------------------------

The expression of *Dusp1* was analyzed in cochlear samples from embryonic day (E) 15.5 to one-year-old mice ([Figure 1A](#fig1){ref-type="fig"}). *Dusp1* transcripts were expressed at all the ages studied, with expression levels increasing by 2-fold at the age of cochlear maturation (2 months) and 4-fold at the oldest age studied (12 months) with respect to those at the earliest embryonic age studied. The expression of *Dusp1*, as well as that of other members of the inducible nuclear MAP kinase phosphatases family, *Dusp2*, *Dusp4* and *Dusp5*, was then studied in cochlear samples of 2-month-old wildtype and *Dusp1* null mice. As expected, *Dusp1* was not expressed in the null mouse, whereas *Dusp2* expression was significantly increased in these mice when compared to wildtype mice ([Figure 1B](#fig1){ref-type="fig"}). These differences were maintained at the ages of 4--5 and 8--9 months, and at 8--9 months, *Dusp5* expression was also significantly reduced in *Dusp1* null mice compared to wildtype mice ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Furthermore, we confirmed both the absence of DUSP1 and its induction by stress stimuli in Mouse embryonic fibroblast (MEF) cells. E13.5 MEFs were prepared from wildtype and null mice and exposed to UVC light for 30 min. As expected, MEFs prepared from wildtype mice but not those from null mice showed a rapid induction of DUSP1 levels following stress ([Figure 1C](#fig1){ref-type="fig"}).

![Expression of *Dusp1* and related phosphatases in the mouse cochlea.\
(**A**) Cochlear gene expression of *Dusp1* in MF1 × 129 Sv mice from embryonic (E) to adult stages (measured in days (d) and months (m)). Expression levels were measured by RT-qPCR and calculated as 2^--ΔΔCt^ (RQ), using *Hprt1* as the reference gene and normalized to data from 1--2 month-old mice. Values are presented as mean ± SEM of triplicates from pool samples of three mice per condition. Statistically significant differences were analyzed by Student's t-test, \*\*\*p\<0.001. (**B**) Cochlear gene expression of inducible nuclear MKPs in the cochlea of 2-month-old *Dusp1^+/+^* (light yellow) and *Dusp1^--/^*^--^ mice (dark yellow). Expression levels were calculated as 2^--ΔΔCt^ (RQ), using *Rplp0* as the reference gene and normalized to 2-month-old wildtype *Dusp1* expression. Data are presented as mean ± SEM of triplicates from pool samples of three mice per condition. Statistically significant differences were analyzed by the Student's t-test (\*\*p\<0.01 and \*\*\*p\<0.001). (**C**) MEFs cells from *Dusp1^+/+^* or *Dusp1^--/^*^--^mice were treated or not with 20 J/cm^2^ UVC light and harvested 30 min after stimuation. 20 μg of whole cell extracs (WCE) were resolved in SDS-PAGE and DUSP1 expression was detected using a specific antibody. Tubulin was used as a loading control.](elife-39159-fig1){#fig1}

On the other hand, no further differences between genotypes were found in the expression of other MKPs ([Figure 1---figure supplement 1A--C](#fig1s1){ref-type="fig"}), nor in the age-evolution of the expression profiles of MAPKs 11 to 14 ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}).

Expression of *Dusp1* is necessary for maintenance of hearing {#s2-2}
-------------------------------------------------------------

Hearing was assessed in 1- to 12-month-old mice by evaluating the auditory brainstem response (ABR) in longitudinal experiments ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Null mice showed elevated ABR thresholds from the age of 2 months when compared to wildtype littermates, although 2-month thresholds were in the range of normal-hearing, showing the typical five waves in response to click sounds ([Figure 2A](#fig2){ref-type="fig"}). However, the evolution of null mice hearing thresholds worsened with age in response to click and, particularly, to high frequencies presented in tone pure bursts ([Figure 2B](#fig2){ref-type="fig"}). Thus, we observed premature hearing loss that progressed rapidly from moderate (4--5 months) to profound (8--9 months onward) and affected hearing of initially high and later low frequencies. At the age of 12 months, null mice showed cophosis and therefore no further tests were carried out beyond this age. By contrast, wildtype mice showed cophosis at later ages, between 16--19 months (n = 3, data not shown). Hearing was also assessed in 2-, 5- and 8-month-old *Dusp1* heterozygous mice, no differences in ABR thresholds were found when comparing with wildtype mice (data not shown).

![Comparative longitudinal hearing evaluation of *Dusp1^+/+^* and *Dusp1^--/^*^--^ mice.\
(**A**) Representative ABR recordings showing the typical I--V waves obtained in response to click stimuli from *Dusp1^+/+^* and *Dusp1^--/^*^--^ mice of 2, 4--5, 8--9 and 12 months of age, showing the hearing thresholds (colored bold lines). (**B**) Evolution of ABR thresholds (mean ± SEM) in response to click and tone burst stimuli in *Dusp1^+/+^* (lighter color lines) and *Dusp1^--/^*^--^ (darker color lines) mice of 2 (*Dusp1^+/+^*, n = 26; *Dusp1^--/^*^--^, n = 25), 4--5 (*Dusp1^+/+^*, n = 25; *Dusp1^--/^*^--^, n = 24), 8--9 (*Dusp1^+/+^*, n = 24; *Dusp1^--/^*^--^, n = 22) and 12 months of age (*Dusp1^+/+^*, n = 7; *Dusp1^--/^*^--^, n = 3). (**C**) Input--output function of wave I latency, the mean latency (± SEM) of ABR peak one is plotted against sound intensity (dB SPL) for mice of 4--5 (*Dusp1^+/+^*, n = 25; *Dusp1^--/^*^--^, n = 24) and of 8--9 months of age (*Dusp1^+/+^*, n = 22; *Dusp1^--/^*^--^, n = 21). (**D**) Interpeak latency (mean ± SEM) between peaks I--II, II--IV and I--IV obtained at 80 dB SPL click stimulation in mice of 4--5 (*Dusp1^+/+^*, n = 25; *Dusp1^---/^*^--^, n = 24) and 8--9 months of age (*Dusp1^+/+^*, n = 21; *Dusp1^--/^*^--^, n = 21). Statistically significant differences were analyzed by Student's t-test comparing genotypes (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001).](elife-39159-fig2){#fig2}

The speed of transmission of the auditory signal was studied by analyzing the latency of appearance of the successive ABR waves elicited by the click stimulus, which was presented at a range of low to high intensities. Null mice showed a significant delay on wave I latency from the age of 2 months ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), which was maintained in 4--5- and 8--9-month-old mice ([Figure 2C](#fig2){ref-type="fig"}). Latencies of waves II and III, but not of IV, also showed significant delays in null mice at the latest ages studied (data not shown). However, null mice showed a significant decrease in the values of I--IV and II--IV interpeak latencies from the age of 4--5 months onwards when compared to wildtype mice of matched ages ([Figure 2D](#fig2){ref-type="fig"}). No differences were found between genotypes in interpeak latencies in young (2-month-old) mice. Still, even young null mice showed delay on wave I appearance and decreased amplitudes of wave I and IV, which continued for wave IV at 4--5 months of age ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

These data taken together indicate that *Dusp1* null mice show a premature and progressive sensorineural hearing loss.

Progressive hearing loss of *Dusp1^--/^*^--^ mice correlates with cochlear cellular alterations {#s2-3}
-----------------------------------------------------------------------------------------------

Study of the gross anatomy of the middle ear ossicles and inner ear of 2-month-old mice showed no evident morphological alterations between genotypes ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). The subsequent morphological evaluation of cochlear sections of mice of both genotypes indicated that 2-month-old mice showed no evident differences, and a normal cytoarchitecture in the basal and middle turns of the cochlea was observed ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Three months later, young adult wildtype mice maintained unaltered cochlear morphology ([Figure 3A,a--d](#fig3){ref-type="fig"}), whereas *Dusp1* null mice already showed loss of hair and supporting cells in the organ of Corti, loss of neural cells of the basal spiral ganglion ([Figure 3A,e--h](#fig3){ref-type="fig"}) and loss of of spiral ligament fibrocytes (data not shown). Cochlear cell loss showed a base to apex gradient that progressed with age in concordance with the aforementioned worsening of thresholds from high to low frequencies ([Figure 2](#fig2){ref-type="fig"}). Therefore, 8-month-old null mice showed loss of cells at the organ of Corti in the middle turn of the cochlea, whereas damage to ganglion cells was evident in the basal turn and extended to the middle turn ([Figure 3A,m--p](#fig3){ref-type="fig"}). By contrast, 8-month-old wildtype mice still conserved a well-preserved cytoarchitecture ([Figure 3A,i--l](#fig3){ref-type="fig"}). No differences were observed in the apical turn of the cochlea in 8-month-old mice of different genotypes (data not shown).

![Comparative cochlear cytoarchitecture of *Dusp1^+/+^* and *Dusp1^--/^*^--^ mice.\
(**A**) Representative microphotographs of hematoxylin-eosin-stained paraffin cochlear mid-modiolar sections of *Dusp1^+/+^* and *Dusp1^--/^*^--^ mice, showing the spiral ganglion and the organ of Corti from the middle and basal turns of the cochlea at 4--5 (n = 5 per genotype) and 8--9 months of age (n = 5 per genotype). Insets present representative microphotographs of myelin protein p0 immunohistochemistry from the middle and basal turns of the cochlea at 4--5 (n = 3 per genotype) and 8--9 months of age (n = 3 per genotype). Asterisks and arrowheads indicate the absence of neural and hair cells, respectively. Scale bars: 25 µm. IHC, inner hair cell; OHC, outer hair cell. (**B**) Cochlear gene expression of *Mpz*, *NeuN*, *Sox2* and *Prestin* in *Dusp1^+/+^* (lighter color bars) and *Dusp1^--/^*^--^ mice (darker color bars) at 2, 4--5 and 8--9 months of age. Expression levels were measured by RT-qPCR and calculated as 2^--ΔΔCt^ (RQ), using *Rplp0* as reference the gene and normalized to the 2-month-old wildtype mice group. Values are presented as mean ± SEM of triplicates from pool samples of three mice per condition. Statistically significant differences were analyzed by Student's t-tests comparing genotypes (\*\*p\<0.01 and \*\*\*p\<0.001). (**C**) TUNEL apoptosis detection. Representative confocal maximal projection microphotographs show the spiral ganglion of the middle and basal turns of 4--5 month-old *Dusp1^+/+^* (light green bars, n = 4) and *Dusp1^--/^*^--^ (dark light bars, n = 3) mice. Arrowheads indicate positive TUNEL cells. Quantification of positive TUNEL cells is shown as the percentage of total DAPI-positive cells in a region of interest (ROI) in the spiral ganglion. Values are presented as mean ± SEM. Statistically significant differences were analyzed by Student's t-tests comparing genotypes (\*p\<0.05). Scale bar: 25 µm.](elife-39159-fig3){#fig3}

Cellular loss was further confirmed by testing the gene expression of molecular markers of specific cochlear cell populations. Thus, *Mpz,* is expressed in the spiral ganglion and cochlear nerve as the major component of the peripheral nervous system myelin sheath ([@bib107]). The RNA-binding *RbFox3/NeuN-*coding nuclear factor is expressed in post-mitotic neurons and is involved in the development and maintenance of neuronal functions ([@bib53]; [@bib75]). The transcription factor *Sox2* is required for inner ear development and is expressed by Schwan cells and supporting cells in the adult cochlea ([@bib36]; [@bib92]). Finally, the gene *Prestin* encodes the homonymous motor protein that is specifically expressed in outer hair cells ([@bib112]).

[Figure 3B](#fig3){ref-type="fig"} shows that *NeuN* transcript levels were significantly decreased in null *Dusp1^--/^*^--^ compared to wildtype mice over the ages studied. Loss of *Prestin* was also evident, and there was a statistically significant difference between genotypes in 8--9-month-old mice. Furthermore, the TUNEL assay confirmed that cochlear cell loss was apoptotic, thus [Figure 3C](#fig3){ref-type="fig"} shows apoptotic neural cell death in the basal and middle cochlear turns of 4--5-month-old null mice. At the oldest age studied, 12 months, cell degeneration progressed but showed individual variability, the most damaged null mouse even showed outer hair cell loss in the apical turn (1 out of 3 mice studied), whereas the apical turn in wildtype animals showed no alterations (2 out of 2 mice studied).

A more detailed examination of the organ of Corti of 5-month-old null mice revealed a widespread degeneration of hair cells (myosin VIIa immunoreactivity) and nerve fibers (neurofilaments) that was not observed in wildtype mice ([Figure 4A](#fig4){ref-type="fig"}). A count of the hair cells on whole-mount preparations confirmed the loss of hair cells in null mice, revealing significantly fewer outer hair cells (OHC) and also inner hair cells (IHC) at the basal turn of the organ of Corti ([Figure 4B](#fig4){ref-type="fig"}). DPOAE recordings of OHC activity further confirmed cell loss and showed significant threshold increases in null compared to wildtype mice from the age of 4--5 months ([Figure 4C and D](#fig4){ref-type="fig"}). OHC malfunction progressed with age and maintained a significant difference between genotypes. The study of the distortion product otoacoustic emissions (DPOAE) input--output (I/O) functions of emission amplitudes evoked by f2 = 10.9 and 15.2 kHz is shown in [Figure 4D](#fig4){ref-type="fig"}. DPOAE I/O functions were significantly lower for 4--5-month-old null mice in the highest frequency studied, and the differences between genotypes progressed to lower frequencies as the mice aged ([Figure 4D](#fig4){ref-type="fig"}).

![Organ of Corti degeneration in *Dusp1^--/^*^--^ mice.\
(**A**) Representative confocal maximal projection images of the organ of Corti of the middle and basal turns of 5-month-old *Dusp1^+/+^* (n = 4) and *Dusp1^--/^*^--^ (n = 4) mice immunolabeled for hair cells MyoVIIA (green), neurofilament (red) and phalloidin (purple). Asterisks and arrowheads indicate the absence or presence, respectively, of hair cells and fibers. Scale bar: 10 µm. IHC, inner hair cell; OHC, outer hair cell; SB, spiral bundle; TC, tunnel of Corti. (**B**) Quantification in the middle (35--45% distance from apex) and basal cochlear turns (60--70% distance from apex) of 5-month-old *Dusp1^+/+^* (light green bars) and *Dusp1^--/^*^--^ (dark green bars) mice of the number of outer (base, n = 3 per genotype; middle, n = 4 per genotype) and inner hair cells (base, n = 4 per genotype; middle n = 4, per genotype). Values are presented as mean ± SEM. (**C**) DPOAE thresholds (mean ± SEM) of *Dusp1^+/+^* (light color lines) and *Dusp* ^--^/^--^ (dark color lines) mice of 4--5 months of age (8 kHz: *Dusp1^+/+^*, n = 5, *Dusp1^--/^*^--^, n = 8; 10 kHz: *Dusp1^+/+^* n = 4, *Dusp1^--/^*^--^, n = 8; 14 kHz: *Dusp1^+/+ ^*n = 4, *Dusp1^--/^*^--^ n = 7) and 8--9 months of age (8 kHz: *Dusp1^+/+^*n = 5, *Dusp1^--/^*^--^, n = 5; 10 kHz: *Dusp1^+/+ ^*n = 4, *Dusp1^--/-- ^*n = 5; 14 kHz: *Dusp1^+/+ ^*n = 4, *Dusp1^--/--^* n = 4). (**D**) DPOAE amplitude I/O function (mean ± SEM) evoked by stimulus (f2 = 10.9 kHz or f2 = 15.2 kHz) of *Dusp1^+/+^* (lighter color lines) and *Dusp1^--/^*-- (darker color lines) for mice of 4--5 and 8--9 months of age (at least three mice per genotype). Statistically significant differences were analyzed by Student's t-tests comparing genotypes (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001).](elife-39159-fig4){#fig4}

*Dusp1* deficit leads to an early redox imbalance in the cochlea {#s2-4}
----------------------------------------------------------------

To further understand the molecular mechanisms underlying the pathological hearing loss phenotype caused by the deficiency in *Dusp1*, we studied oxidative stress and inflammation as two of the main hallmarks of ageing ([@bib55]) that are closely related with the activity of DUSP1. The oxidative status was evaluated first by measuring the expression levels of genes involved in redox regulation ([Figure 5A](#fig5){ref-type="fig"}). At the molecular level, by the age of just 2 months, differences were observed between genotypes in a subset of the genes studied. Transcripts of enzymes involved in glutathione homeostasis(*Gpx1* \[1.8-fold\] and *Gsr* \[1.5-fold\]) and in glutathione synthesis(*Gclm* \[1.5-fold\]) showed a significant increase in null mice. However, no induction of the expression of these genes was found at the other ages studied ([Figure 5A](#fig5){ref-type="fig"}, first and second rows). Mitochondrial *Ucp1* showed decreased (1.7-fold) and NADPH oxidase components increased (*Nox3* \[3-fold\] and *Cyba* \[1.4-fold\]) expression levels in 2-month-old null mice compared with wildtype mice of the same age. *Cyba* transcripts equalized at the age of 5 months between genotypes, but cochlear *Ucp1* and *Nox3* dysregulation was observed at all the ages studied in null mice. No differences between genotypes were observed in *Nox4* expression levels ([Figure 5A](#fig5){ref-type="fig"}, third row). Finally, analysis of the apoptosis-related genes *Apaf1* and *Kim1* showed no expression differences between genotypes for *Apaf1* but a 2.2-fold increase in the expression of Kim1 in null mice when compared to wildtype mice at 2 and 5 months ([Figure 5A](#fig5){ref-type="fig"}, fourth row). Accordingly, 5-month-old null mice showed decreased cochlear levels of the mitochondrial antioxidant manganese superoxide dismutase (MnSOD, 1.5-fold). As well as increased levels of P22phox (1.4-fold), of the beta isoform of apoptosis regulator BCL-2-associated X (BAXβ, 1.7-fold) and of phosphorylated p38 (1.4-fold) with respect to wildtype mice ([Figure 5B](#fig5){ref-type="fig"}). No significant differences were observed in the activation levels of JNK or ERK.

![Cochlear oxidative stress status of *Dusp1^+/+^* and *Dusp1^--/--^* mice.\
(**A**) Cochlear expression of redox regulation and apoptosis genes in *Dusp1^+/+^* (lighter color bars) and *Dusp1^--/^*^--^ mice (darker color bars) of 2, 4--5 and 8--9 months of age. Expression levels were measured by RT-qPCR and calculated as 2^--ΔΔCt^ (RQ), using *Rplp0* as the reference gene and normalized to data from the 2-month-old wildtype mice group. Values are presented as mean ± SEM of triplicates from pool samples of three mice per condition. (**B**) Cochlear protein relative levels were measured by western blotting. Representative blots and quantification of levels are shown for γ-H2AX, P22phox, MnSOD, BAXβ, P-p38, P-JNK and P-ERK1/2 cochlear protein extracts from 5-month-old *Dusp1^+/+^* (light green bars) and *Dusp1^--/^*^--^ mice (dark green bars). Expression levels were calculated as a ratio using PI3K as housekeeping protein and normalized to the wildtype mice group. Values are presented as mean ± SEM of triplicates from pool samples of three mice per condition. Statistically significant differences were analyzed by Student's t-tests comparing genotypes (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001).](elife-39159-fig5){#fig5}

These data suggested that DUSP1 deficiency generates redox imbalance in young mice, which can progressively trigger inflammation and apoptotic cell death. Reinforcing this hypothesis, we observed stronger 3-nitrotyrosine (3-NT) immunoreactivity, a consequence of the nitration of tissue proteins by free radicals, in neural cells of the spiral ganglion in 2-month-old null mice ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

To confirm that the absence of DUSP1 increases the levels of reactive oxygen species (ROS), we next studied the response of MEF cells derived from *Dusp1^+/+^* and *Dusp1^--/--^* mice to the oxidant stimulus H~2~O~2~. Our data showed that H~2~O~2~ strongly increased ROS levels in *Dusp1^--/--^* compared to *Dusp1^+/+^* cells ([Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"}). These results reinforced the theory that the absence of DUSP1 modulates oxidative stress in MEF cells. To further assess the possibility that DUSP1 deficiency leads to DNA damage and, eventually, to cell death, we next quantified γ-H2AX-associated foci in MEF cells from both genotypes. The results showed that cells derived from *Dusp1^--/--^* mice showed more foci per cell than *Dusp1^+/+^* cells, indicating DNA damage in basal conditions ([Figure 5---figure supplement 2B](#fig5s2){ref-type="fig"}).

*Dusp1* deficit triggers an exacerbated inflammatory response {#s2-5}
-------------------------------------------------------------

Subsequently, we studied the cochlear expression of genes that encode proinflammatory and anti-inflammatory mediators ([Figure 6A](#fig6){ref-type="fig"}). We found a significant increase in the expression of the anti-inflammatory interleukin 10 gene (*Il10,* 2-fold) together with a decrease in the expression of *Foxp3* (1.4-fold) in 2-month-old null mice. Interestingly, progression of hearing loss is correlated to inflammatory dysregulation, with pro-inflammatory cytokines being strongly upregulated in null mice from the age of 5 months. Thus *Il1b, Tnfa* and *Tgfb1* expression levels were increased by 1.7, 1.6 and 1.6-fold, respectively, in the null mouse. By contrast, *Il6* showed no expression differences and increased with ageing similarly in both genotypes.

![Exacerbated inflammatory response in *Dusp1^--/--^* mice.\
(**A**) Cochlear expression of inflammatory response genes in *Dusp1^+/+^* (lighter color bars) and *Dusp1^--/--^* mice (darker color bars) of 2, 4--5 and 8--9 months of age. Expression levels were calculated as 2^--ΔΔCt^ (RQ), using *Rplp0* as the reference gene and normalized to the 2-month-old wildtype mice group. *Il10* data were normalized to the matched-age wildtype mice groups. Values are presented as mean ± SEM of triplicates from pool samples of three mice per condition. (**B**) Representative microphotographs of cochlear mid-modiolar cryosections immunolabeled for IBA1, showing a detail of the spiral ligament of the apical, middle and basal turns of 5-month-old *Dusp1^+/+^* (n = 3) and *Dusp1^--/--^* mice of 5 (n = 3) and 8 months of age (n = 3). The Type IV fibrocytes region is outlined. Arrowheads point to macrophage cells. Scale: 50 µm. (**C**) IBA1 total fluorescence intensity was measured in the spiral ligament in each cochlear turn of 5-month-old *Dusp1^+/+^* (light green bars; base, n = 4; middle, n = 5; apical, n = 4) and *Dusp1^--/--^* mice of 5 months (dark green bars, base, n = 4; middle, n = 6; apical, n = 5) and 8 months of age (dark blue bars, base, n = 4; middle, n = 3; apical, n = 3). Values are presented as mean ± SEM. Statistically significant differences were detected by Student's t-test comparing genotypes (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001).](elife-39159-fig6){#fig6}

Infiltration by IBA1^+^ macrophages is part of the inflammatory and phagocytic cochlear response to damage. Five- and 8-month-old null mice showed more macrophage infiltration than did wildtype mice ([Figure 6B](#fig6){ref-type="fig"}, compare the first two columns), with IBA1^+^ cells in the spiral ligament in a gradient from base to apex ([Figure 6B](#fig6){ref-type="fig"}, quantification in Figure6C), and a progression with age ([Figure 6B](#fig6){ref-type="fig"}, compare central and right columns).

To further study the contribution of DUSP1 in inflammation, MEFs prepared from wildtype and null mice were treated with TNFα (10 ng/ml) for different periods of time ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). The results showed that TNFα induced p38 in both genotypes, but that the molecular apoptotic marker Caspase 3 is cleaved (activated) only in *Dusp1^--/--^* mice 4 hr after treatment ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

DUSP1 deficit increases and MAPK14 deficit reduces noise-induced hearing loss {#s2-6}
-----------------------------------------------------------------------------

Exposure to noise accelerates the loss of hearing that is associated with ageing. ARHL and noise-induced hearing loss (NIHL) are associated with increased ROS production, inflammation and OHC apoptosis ([@bib47]; [@bib109]). To test whether DUSP1 deficit influenced the extent of noise-induced insult, 2-month-old *Dusp1* null and wildtype mice were exposed to noise. Three days later, the *Dusp1* null mice were severely damaged, especially in frequencies over 8 kHz, when compared with wildtype mice ([Figure 7A](#fig7){ref-type="fig"}). Differences between genotypes at 16 kHz and 20 kHz were maintained 14 days after noise exposure. *Dusp1^+/-- ^*heterozygotes showed a response similar to that of wildtype mice (data not shown). To confirm that noise induces DUSP1 in wildtype mice, cochlear samples were taken 45 and 90 min after noise exposure, and DUSP1 levels were measured by western blotting. Indeed, noise transitorily induced DUSP1 (for around 45 min after the noise). P-p38 was also tested in parallel but, as described, it was not increased at these early post-noise timepoints ([Figure 7B](#fig7){ref-type="fig"}). Thus, to further confirm that the level of phosphorylation of stress kinases is essential for the progression of noise insult, tamoxifen (TAM)-treated *Mapk14* conditional knockin (KI/KI and +/KI) and wildtype (+/+) mice were also exposed to noise. No differences in hearing thresholds were detected among these genotypes following TAM treatment ([Figure 7C](#fig7){ref-type="fig"}, left panel, baseline). Mice with a total or partial deficiency in *Mapk14* showed ABR threshold shifts that were smaller than those shown by wildtype mice from the first time tested, suggesting that *Mapk14* activation plays a central role in the progression of noise-induced injury.

![Hearing loss following noise-exposure of *Dusp1* and *Mkp14* null mice.\
(**A**) ABR thresholds (mean ± SEM) in response to click and tone burst stimuli before noise exposure (baseline) and 3 and 14 days post-noise (VSS, 107 dB, 30 min) exposure in *Dusp1^+/+^* and *Dusp1^--/--^* mice (n = 4 per genotype). (**B**) Representative blots and quantification of levels are shown for DUSP1 and P-p38 cochlear protein extracts from *Dusp1^+/+^* and *Dusp1^--/--^* mice and wildtype mice, 45 and 90 min after noise exposure. Expression levels were calculated as a ratio using PI3K as the loading control. Values are presented as mean ± SEM of triplicates from pool samples of three mice per condition. (**C**) Evolution of ABR thresholds (mean ± SEM) in response to click and tone burst stimuli before (baseline) and 3 and 14 days post-noise exposure in *Mkp14*^+/+^ and *Mpk14*^KI/KI^ mice (n = 7 per genotype). Statistically significant differences were analyzed by Kruskal--Wallis tests comparing genotypes (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001).](elife-39159-fig7){#fig7}

Discussion {#s3}
==========

In this work, we show that *Dusp1* plays a key role in hearing maintenance and, therefore, its deficit accelerates progressive hearing loss as mice age. DUSP1-deficient mice show progressive hearing loss with age, and cochlear cellular degeneration progresses with age from the cochlear base to the apex.

DUSP1 has been classified as an inducible nuclear phosphatase but it has also been found in cytosol, mitochondria and peroxisomes ([@bib43]). This protein dephosphorylates MAPK proteins, with substrate specificity for p38 and JNK ([@bib77]). DUSP1 is an early-response gene that is induced transitorily by different stress-related stimuli ([@bib28]). DUSP1 expression is low during development in almost all tissues except liver and intestine. RNAseq studies indicate that it is expressed in the cochlea and vestibule, particularly in supporting cells (data available from gEAR, umgear.org) ([@bib9]; [@bib23]; [@bib54]; [@bib86]), and that it is upregulated in the cochlea after exposure to noise ([@bib1]). In general, MKP family members have been reported to present low basal levels of expression in most tissues ([@bib11]) but they are rapidly induced after stress stimuli. Accordingly, we have observed here that DUSP1 expression is induced in *Dusp1^+/+^* MEF by 30 min of UV irradiation and in *Dusp1^+/+^* cochlea by 30 min of exposure to noise.

The MKP family includes many members that have broad substrate specificity. Studies using MKP-deficient in vivo models have shown that the deletion of one family member typically results in a complex phenotype, which reflects the complex transcriptional regulation of these proteins by MAP kinases and the compensatory effects of other MKPs ([@bib35]). In this work, we have observed that *Dusp1* transcripts show their highest expression levels in the cochlea among the nuclear-inducible MKPs, and interestingly that these expression levels increase with age. These data suggest that an increase in DUSP1 expression level is required to maintain hearing with age. Other family members do not seem to compensate for the specific action of DUSP1 in the cochlea, although they could potentially contribute to ameliorating the hearing phenotype through the increased expression of *Dusp2*. DUSP2 is a nuclear phosphatase, enriched in hematopoietic cells, that is specific for ERK and p38. It is a positive regulator of inflammatory response, and so the macrophages of *Dusp2* null mice produce lower levels of pro-inflammatory cytokines. This deficit is accompanied by the decreased and increased activation of ERK and JNK, respectively ([@bib73]). However, as none of the MKPs studied here showed expression changes as the mice aged, it seems that there are no alternative compensatory mechanisms to DUSP1 protection in age-related hearing loss.

MKP family members *Dusp6*, *Dusp7* and *Dusp9*, which mainly target ERK1/2, have been reported to be expressed during inner ear development ([@bib101]). Indeed, the inactivation of *Dusp6* leads to hypoacusis that results from malformations in the middle ear and otic capsule but not in the cochlea ([@bib52]). By contrast, we show here that DUSP1 deficit does not affect either middle ear or otic capsule formation. Indeed, the hearing-loss phenotype of the null mice has a clear correlation with the progressive loss of cochlear cell populations, particularly the loss of the hair and supporting cells of the organ of Corti and of the neural cells of the spiral ganglion. Reported human ARHL cochlear alterations include changes to structural elements such as hair cells, neurons, lateral wall tissues, or a combination thereof ([@bib48]; [@bib70]). Thus, the cochlear phenotype of the *Dusp1* null mouse reproduces that reported for human ARHL, and shares characteristics with other animal models of progressive hearing loss ([@bib22]; [@bib24]; [@bib80]), including increased apoptotic cell death in the ageing cochlea ([@bib89]).

Our data suggest that the activity of DUSP1 is an essential piece of the molecular mechanism involved in otoprotection during ageing. Indeed, DUSP1 has already been described as neuroprotective ([@bib16]; [@bib97]) and as a regulator of neuroinflammatory processes ([@bib17]). Low levels of DUSP1 have been associated with neurological pathologies such as Huntington disease, multiple sclerosis, ischemia or cerebral hypoxia ([@bib17]). Interestingly, BDNF-induced axon branching is regulated by DUSP1 during development ([@bib39]; [@bib65]). Although 2-month-old null mice already have worse hearing thresholds than their wildtype littermates, we did not observe a gross cochlear developmental defect. Nevertheless, these young mice already show defective temporal processing and responsiveness of auditory signal. As in other murine models of ARHL, at later ages this defect is not compensated for in the central stations of the auditory pathway ([@bib62]). These differences were not observed in one-month-old null mice, suggesting that young null mice have subtle hearing deficiencies that are most possibly related to alterations in basic molecular mechanisms.

The increased production of ROS found in H~2~O~2~-stimulated MEF from embryonic null mice supports this concept, and points to chronic oxidative stress as one of the possible causes of later problems. This redox imbalance was further confirmed in the cochlea of young null mice by the detection of 3-NT, a metabolite of peroxynitrite action that is increased in the ageing ear ([@bib40]). Indeed, abnormally increased ROS levels play a role in ageing and in the onset and progression of age-related diseases ([@bib3]), including presbycusis ([@bib110]). Mitochondria are the source of 90% of intracellular ROS, which are a byproduct of mitochondrial respiration, and one of the main targets of the oxidative damage caused by them. ROS can also be generated by non-mitochondrial sources such as the NADPH oxidases ([@bib19]). DUSP1 upregulation is induced by ROS, specifically by those produced by NADPH oxidases ([@bib27]), and the transitory expression of this protein can also be stabilized by RNA-binding proteins in contexts of oxidative stress ([@bib49]). Interestingly, the observed cochlear cell loss follows a gradient from base to apex. It is well known that basal structures are more susceptible in general to insult ([@bib67]; [@bib85]; [@bib94]) and in particular to ageing ([@bib57]; [@bib69]; [@bib72]). It has been proposed that higher basal susceptibility to damage is the result of increased ROS generation ([@bib15]) and that basal hair cells are highly damaged by free oxygen radicals ([@bib88]).

*Dusp1* null mice present an early decrease of mitochondrial uncoupling protein 1 (UCP1), as well as an imbalance of NAPDH oxidases. Uncoupling proteins facilitate the dissipation of the proton gradient needed for oxidative phosphorylation, leading to heat generation and reduced ROS generation by mitochondria ([@bib45]). UCP1--UCP5 are expressed in the spiral and vestibular ganglia and are upregulated by some stress stimuli ([@bib46]; [@bib81]). On the other hand, the NADPH oxidase NOX3 constitutively generates superoxide, which is further converted to H~2~O~2~, in a p22PHOX-dependent manner. NOX3 is expressed in the vestibular and cochlear sensory epithelium and spiral ganglion ([@bib4]). NOX3 is downregulated by noise ([@bib105]) and participates in cisplatin-induced superoxide formation and ototoxicity ([@bib44]). Protection from ROS-induced damage is achieved by a complex system of antioxidant enzymes: superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and peroxiredoxin ([@bib78]). It has been proposed that, with ageing, the imbalance between increased production and impaired detoxification systems leads to a pro-oxidative state ([@bib71]). Thus, natural ageing could lead to oxidative damage to hair cells and ganglion neurons, which require great amounts of energy to process sound, ultimately leading to cell and functional loss ([@bib61]).

In fact, oxidative stress and mitochondrial dysfunction are the underlying mechanisms pointed to by many of the uncovered genetic factors associated with ARHL. For example, genetically modified mice that have defects affecting *Gpx1*, *Sod1*, *Polg1*, *mt-Tr*, and *Cs* show traits of ARHL ([@bib8]; [@bib66]). Human genetic studies of ARHL have also identified polymorphisms of genes in the same functional category, such as *CAT*, *MTHFR*, *MTR*, and *UCP2,* within a single cohort ([@bib18]). The glutathione-transferase genes (*GSTM1* and *GSTT1*) ([@bib5]; [@bib102]) and N-Acetyltransferase 2 (*NAT2*) have also been studied extensively and associated with human ARHL ([@bib100]; [@bib102]). *Dusp1* null mice present an early imbalance in ROS-detoxifying enzymes (MnSOD) and in glutathione synthesis (*Glcm*) and metabolism (*Gpx1* and *Gsr*) enzymes. A functional imbalance is implied because levels of mRNAs encoding antioxidant enzymes have been shown to correlate with protein levels and enzyme activities ([@bib37]; [@bib91]; [@bib95]). Ageing is associated with increasing oxidation, the progression of cellular damage and cell death, but here, levels mRNAs that encode redox enzymes are altered only in 2-month-old null mice. This situation could be similar to that reported in apolipoprotein E (APOE)-deficient mice, in which a pre-lesion increase in antioxidant enzymes is followed by a decrease once the vascular lesion is extended ([@bib32]).

Taken together, these results suggest the existence of a pro-oxidative stage predisposition in the DUSP1-deficient mouse. Our data point to the activation of MAPK14 as the possible link between the absence of DUSP1 and a premature increase in cochlear oxidative stress and pro-inflammatory status. MAPK14 is expressed in the cochlea ([@bib76]; [@bib83]) and it is activated at different time points after noise insult ([@bib38]; [@bib56]; [@bib68]), as well as during ageing ([@bib89]). We show here that DUSP1 is induced by noise-exposure and that its transcription increases with age. MAPK14 inhibitors attenuate mitochondrial and cytoplasmic ROS production in DUSP1-deficient macrophages ([@bib96]). In this sense, the suppression of MAPK14 activity has been linked with protection from mitochondrial dysfunction and ROS generation in different pathologies ([@bib34]; [@bib111]). Furthermore, the inhibition of MAPK14 downregulates the expression of NADPH oxidase, whereas the activation of MAPK14 induces the phosphorylation and activation of NADPH oxidase subcomponents, potentially leading to enhanced ROS production ([@bib58]). These previous sources of evidence are in agreement with our results*: Dusp1* null mice exhibited increased sensitivity to noise exposure, whereas *Mapk14^KI/KI^ mi*ce showed better hearing thresholds and better auditory recovery after the insult than wildtype mice, suggesting an important role of MAPK14/DUSP1 in the progression of stress-induced injury.

*Dusp1* deficiency also leads to an early increase in kidney injury molecule-1 (KIM-1), which is induced in the cochlea after cisplatin treatment ([@bib63]) and is involved in kidney inflammatory processes that regulate macrophage activation and migration ([@bib98]). Chronic inflammation has been associated with the worsening of human presbycusis ([@bib104]). NOX3-produced ROS is coupled with the production of inflammatory cytokines ([@bib64]) and DUSP1 is an important regulator of the innate immune responses ([@bib14]). A chronic inflammatory state that occurs as a consequence of ageing of the immune system (known as 'inflammaging') is another hallmark of cochlear ageing ([@bib42]). In this context, *Dusp1* null mice present an exacerbated inflammatory response from the age of 5 months onwards. Our results suggest that an inflammatory feedback loop may exist in which the presence of inflammatory cytokines, the absence of DUSP1 and the consequent activation of stress kinases enhances cellular apoptosis.

Null mice showed increased expression of cytokines and of IBA1-positive phagocytic cells from the youngest age studied. Interestingly, during normal ageing, resident macrophages increase in number and undergo changes in morphology that are directly associated with the degeneration of sensorial cells ([@bib26]). Chronic inflammation causes damage to cells that are quickly removed from the cochlea ([@bib33]). Resident macrophages and supporting cells of the organ of Corti have been proposed as the effectors of the cleaning of cellular debris ([@bib2]; [@bib31]).

Taken together, our results show that *Dusp1* deficiency accelerates the onset and the progression of age-related hearing loss. Our results therefore suggest that DUSP1 is essential for lifelong cochlear homeostasis.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\           Designation                     Source or reference             Identifiers                                                          Additional information
  (species) or resource                                                                                                                                        
  ----------------------- ------------------------------- ------------------------------- -------------------------------------------------------------------- ----------------------------------
  Genetic reagent\        *Dusp1^-/-^*                    [@bib20]                        RRID:[MGI:4940296](https://scicrunch.org/resolver/MGI:4940296)       R Perona lab\
  (Mus musculus)                                                                                                                                               (Institute of Biomedical\
                                                                                                                                                               Research \'Alberto Sols\',\
                                                                                                                                                               Madrid, Spain)

  Genetic reagent\        *Mapk14^+/KI^; Mapk14^KI/KI^*   [@bib103]                       RRID:[MGI:3716853](https://scicrunch.org/resolver/MGI:3716853)       AR Nebreda lab (Institute\
  (*M. musculus*)                                                                                                                                              for Research in\
                                                                                                                                                               Biomedicine, Barcelona, Spain)

  Cell line\              *Dusp1^--/^*^--^ MEF            [@bib20]                        RRID:[MGI:4940296](https://scicrunch.org/resolver/MGI:4940296)       Primary culture of\
  (*M. musculus*)                                                                                                                                              mouse embryonic fibroblasts,\
                                                                                                                                                               maintained in I\
                                                                                                                                                               Sánchez-Pérez\'s lab

  Antibody                Anti-myelin P0\                 Neuromics                       Neuromics Cat\#\                                                     IHC (1:150)
                          (chicken polyclonal)                                            CH23009;\                                                            
                                                                                          RRID:[AB_2737144](https://scicrunch.org/resolver/AB_2737144)         

  Antibody                Anti-nitrotyrosine\             Merck-Millipore                 Millipore Cat\#\                                                     IHC (1:100)
                          (rabbit polyclonal)                                             AB5411;\                                                             
                                                                                          RRID:[AB_177459](https://scicrunch.org/resolver/AB_177459)           

  Antibody                Anti-IBA1 (goat polyclonal)     Abcam                           Abcam Cat\#\                                                         IHC (1:100)
                                                                                          ab5076;\                                                             
                                                                                          RRID:[AB_2224402](https://scicrunch.org/resolver/AB_2224402)         

  Antibody                Anti-MyoVIIA\                   Proteus                         Proteus Biosciences\                                                 IHC (1:250)
                          (rabbit polyclonal)                                             Cat\# 25--6790;\                                                     
                                                                                          RRID:[AB_2314838](https://scicrunch.org/resolver/AB_2314838)         

  Antibody                Anti-neurofilament\             Merck-Millipore                 Millipore Cat\#\                                                     IHC (1:100)
                          (mouse monoclonal)                                              CBL212;\                                                             
                                                                                          RRID:[AB_93408](https://scicrunch.org/resolver/AB_93408)             

  Antibody                Alexa Fluor 647 Phalloidin      Thermo Fisher Scientific        Thermo Fisher\                                                       IHC (1:1000)
                                                                                          Scientific Cat\#\                                                    
                                                                                          A22287;\                                                             
                                                                                          RRID:[AB_2620155](https://scicrunch.org/resolver/AB_2620155)         

  Antibody                Anti-P-p38\                     Cell Signaling                  Cell Signaling\                                                      WB (1:1000; 1:2000)
                          (rabbit polyclonal)                                             Technology Cat\#\                                                    
                                                                                          9211, RRID:[AB_331641](https://scicrunch.org/resolver/AB_331641)     

  Antibody                Anti-P-JNK\                     Cell Signaling                  Cell Signaling\                                                      WB (1:1000)
                          (rabbit polyclonal)                                             Technology Cat\#\                                                    
                                                                                          4668; RRID:[AB_823588](https://scicrunch.org/resolver/AB_823588)     

  Antibody                Anti-P-ERK\                     Cell Signaling                  Cell Signaling\                                                      WB (1:1000)
                          (rabbit polyclonal)                                             Technology Cat\#\                                                    
                                                                                          9101, RRID:[AB_331646](https://scicrunch.org/resolver/AB_331646)     

  Antibody                Anti-MKP1 (C-19)\               Santa Cruz Biotechnology        Santa Cruz Biotechnology\                                            WB (1:1000)
                          (rabbit polyclonal)                                             Cat\# sc-370;\                                                       
                                                                                          RRID:[AB_631385](https://scicrunch.org/resolver/AB_631385)           

  Antibody                Anti-γ-H2AX Ser139\             Cell Signaling                  Cell Signaling\                                                      IHC (1:200); WB (1:1000)
                          (rabbit polyclonal)                                             Technology Cat\#\                                                    
                                                                                          2577; RRID:[AB_2118010](https://scicrunch.org/resolver/AB_2118010)   

  Antibody                Anti-P22phox\                   Santa Cruz Biotechnology        Santa Cruz Biotechnology\                                            WB (1:250)
                          (rabbit polyclonal)                                             Cat\# sc-20781;\                                                     
                                                                                          RRID:[AB_2090309](https://scicrunch.org/resolver/AB_2090309)         

  Antibody                Anti-MnSOD\                     Merck-Millipore                 Millipore Cat\#\                                                     WB (1:1000)
                          (rabbit polyclonal)                                             06--984;\                                                            
                                                                                          RRID:[AB_310325](https://scicrunch.org/resolver/AB_310325)           

  Antibody                Anti-BAX (NT)\                  Merck-Millipore                 Millipore Cat\#\                                                     WB (1:1000)
                          (rabbit polyclonal)                                             ABC11;\                                                              
                                                                                          RRID:[AB_10561771](https://scicrunch.org/resolver/AB_10561771)       

  Antibody                Anti-PI3K\                      Not commercially\                                                                                    WB (1:10,000) From AM\
                          (rabbit polyclonal)             available                                                                                            Valverde\'s lab (Institute\
                                                                                                                                                               of Biomedical Research\
                                                                                                                                                               \'Alberto Sols\', Madrid, Spain)

  Antibody                Anti-p38 (C-20)\                Santa Cruz Biotechnology        Santa Cruz\                                                          WB (1:1000)
                          (rabbit polyclonal)                                             Biotechnology Cat\#\                                                 
                                                                                          sc-535; RRID:[AB_632138](https://scicrunch.org/resolver/AB_632138)   

  Antibody                Anti-caspasa3\                  Cell Signaling                  Cell Signaling\                                                      WB (1:1000)
                          (rabbit polyclonal)                                             Technology Cat\#\                                                    
                                                                                          9662; RRID:[AB_331439](https://scicrunch.org/resolver/AB_331439)     

  Antibody                Anti-β-actin\                   Sigma-Aldrich                   Sigma-Aldrich\                                                       WB (1:10000)
                          (mouse monoclonal)                                              Cat\# A5441;\                                                        
                                                                                          RRID:[AB_4767441](https://scicrunch.org/resolver/AB_4767441)         

  Antibody                Anti-β-tubulin\                 Sigma-Aldrich                   Sigma-Aldrich\                                                       WB (1:1000)
                          (mouse monoclonal)                                              Cat\# T9026;\                                                        
                                                                                          RRID:[AB_47759](https://scicrunch.org/resolver/AB_47759)             

  Commercial\             Dead-End Fluorometric\          Promega                         Promega\                                                             
  assay or kit            TUNEL System                                                    Cat\# G3250                                                          

  Chemical\               TNFα                            Sigma-Aldrich                   Sigma-Aldrich\                                                       (10 ng/ml)
  compound, drug                                                                          Cat\# T6674                                                          

  Software, algorithm     BioSigRP TM                     Tucker Davis\                   RRID:[SCR_014590](https://scicrunch.org/resolver/SCR_014590)         
                                                          Technologies (TDT)                                                                                   

  Software, algorithm     Fiji                            Fiji (<https://fiji.sc/>)       RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)         

  Software, algorithm     SPSS                            IBM                             RRID:[SCR_002865](https://scicrunch.org/resolver/SCR_002865)         

  Software, algorithm     Cell Profiler                   Cell Profiler\                  RRID:[SCR_007358](https://scicrunch.org/resolver/SCR_007358)         
                                                          (<https://cellprofiler.org/>)                                                                        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mice {#s4-1}
----

129S2/SvPas:C57BL/6 wildtype (*Dusp1^+/+^*), heterozygous (*Dusp1^+/^*^--^) and null (*Dusp1^--/--^*) mice were generated and genotyped as reported ([@bib20]). *Dusp1^--/^*^--^ mice are fertile and do not show higher mortality rates than wildtypes. General phenotype data for *Dusp1* knockout mice can be found in the Mouse Genome Database (MGD), Mouse Genome Informatics (MGI: 4940244; <http://www.informatics.jax.org>). Hearing was studied monthly in several cohorts and then data-grouped afterwards into groups of 2, 4--5, 8--9, 12 and 16--19 months. Certain cohorts were used to obtain specific time points for further analysis. Neither male and female wildtype mice nor male and female null mice showed sex-associated differences in auditory phenotype. When indicated, some experiments were performed in wildtype mice with a mixed genetic background of 129/SvEvTac (Taconic) and HsdOla:MF1 (Harlan Laboratories) (129Sv:MF1).

The *Mapk14* knockout mouse is embryo lethal, therefore the conditional knockin mouse *Mapk14^tm2Nbr^*/*Mapk14^tm2Nbr^ Polr2a^tm1(cre/ERT2)Bbd^/Polr2a^+^* (*p38^flox/flox^ Polr2a^KI/+^* (MGI 3716853) was used ([@bib103]). Male and female *p38^flox/flox^ Polr2a^KI/+^* were matted to obtain *p38^flox/flox^ Polr2a^KI/+^* (*Mapk14^+/KI^*), *p38^flox/flox^ Polr2a^KI/KI^* (*Mapk14^KI/KI^*) and *p38^flox/flox^ Polr2a^+/+^* (*Mapk14^+/+^*) littermates. One-month-old mice from the three genotypes were treated intraperitoneally with 4-hydroxytamoxifen (Tamoxifen (TAM), T5648, Sigma-Aldrich, St. Louis, MO, USA, in corn oil, 75 mg/kg/day) or corn oil (C8267, Sigma-Aldrich), 3.75 ml/g/day, for 5 days, following the JAX TAM injection protocol for inducible Cre-derived lines. This protocol achieves the excision of exons 2 and 3 of the gene coding for p38α (*Mapk14*) with high efficiency (85%--95%).

Animal experimentation was conducted in accordance with European Community 2010/63/EU and Spanish RD 53/2013 guidelines.

Cell culture {#s4-2}
------------

Mouse embryonic fibroblasts (MEFs) were prepared from embryos of the different genotypes at day 13.5 of gestation as previously described ([@bib74]). After disaggregation of embryos and brief expansion, MEFs from individual embryos were stored in liquid nitrogen until use. Plating of MEFs after thawing was considered passage 1. Cells were maintained in Dulbecco\'s Modified Eagle Medium (DMEM) containing 10% fetal bovine serum and a cocktail of antibiotics and anti-mycotics in a CO~2~ incubator at 37°C. MEFs prepared from wildtype and null mice were treated with TNFα (10 ng/ml) (T6674, Sigma-Aldrich) at the times indicated.

Hearing evaluation {#s4-3}
------------------

Mice were anesthetized with a mixture of ketamine (100 mg/kg; Imalgene 1000, Merial, Lyon, France) and xylazine (10 mg/kg; Rompun 2%, Bayer, Leverkusen, Germany). Auditory brainstem responses (ABR) were measured using a Tucker Davis Technologies workstation (Tucker Davis Technologies, Alachua, FL, USA). Electrical responses were measured in response to broadband click and 8, 16, 20, 28 and 40 kHz pure tone stimuli, with an intensity range 90--20 dB SPL in 5--10 dB steps, as previously reported ([@bib13]). Peak and interpeak latencies were analyzed at 80 dB SPL above hearing threshold after click stimulation. Recording of distortion product otoacoustic emissions (DPOAEs) was performed after stimulation with f1 and f2 primary tones, with a ratio f2/f1 = 1.2, using a TDT equipment, as described ([@bib60]). Primary tones for 8, 10 and 14 kHz frequencies were tested. Analyses of waves, thresholds and latencies were performed with BioSigRP TM software (Tucker Davis Technologies). ABR registries were taken in different cohorts from the age of 1 month.

Noise exposure {#s4-4}
--------------

To evaluate the susceptibility to noise, 2-month-old mice from the three genotypes (*Dusp1 *mutants, *Mapk14* mutants and wildtype) were exposed to violet swept sine noise at 107 dB SPL for 30 min. The effect of noise exposure on hearing was evaluated by ABR before (baseline) and 3, 14 and 28 days after exposure.

Middle and inner ear dissections and morphological evaluation {#s4-5}
-------------------------------------------------------------

Two-month-old mice of each genotype were administered a lethal dose of pentobarbital (Dolethal, Vétoquinol, Madrid, Spain). The inner ear and the ossicles --- the malleus, incus, and stapes --- of the middle ear were dissected as reported ([@bib82]). Microphotographs of these structures were taken using a digital camera connected to a Leica MZ8 stereo microscope (Leica, Wetzlar, Germany).

Cochlear morphology and immunohistochemistry {#s4-6}
--------------------------------------------

For histological analysis, mice were injected with a pentobarbital overdose and perfused with PBS/paraformaldehyde as previously described ([@bib10]; [@bib83]). Cochleae were then dissected, postfixed and decalcified before being embedded in paraffin or Tissue-Tek OCT (Sakura Finetek, Torrance, CA, USA). Paraffin cochlear sections (7 μm) were either stained with hematoxylin/eosin or used for immunohistochemical investigations with anti-myelin P0 (chicken, 1:150, CH23009, Neuromics, Edina, MN, USA) and anti-nitrotyrosine (rabbit, 1:100, AB5411, Merck-Millipore, Burlington, MA, USA) ([@bib59]). Representative images were taken with a Zeiss microscope connected to a DP70 digital camera (Olympus, Tokyo, Japan).

For immunofluorescence assays, frozen OCT cochlear sections (10 μm) were treated overnight, as described previously ([@bib59]), with anti-IBA1 (goat, 1:100, ab5076, Abcam, Cambridge, UK). Fluorescent images were taken with an epifluorescence (Nikon 90i, Tokyo, Japan) microscope. Analyses of total IBA1 intensity and 3-NT mean gray level were performed with Fiji software v1.51n ([@bib87]). We analyzed the spiral ligament of each cochlear turn in four serial cryosections per animal (preparing at least three mice of each genotype of 4--5 months of age and 8--9 months of age) or the spiral ganglia of the basal and middle turns in four serial paraffin sections per animal (prepared from at least three 2-month-old mice of each genotype).

MEFs cells were fixed in 4% formaldehyde for 20 min, washed with PBS and permeabilized with Triton 0.5% for 10 min, before blocking with BSA 5% for 1 hr. Samples were incubated overnight with the primary antibody γ-H2AX Ser^139^ (rabbit, 1:200, Merck-Millipore) at 4°C, followed by a 1 hr incubation with the adequate secondary antibody (1:500, Alexa Fluor 488, Invitrogen) at room temperature. DNA was stained with DAPI. Fluorescence microscopy was performed using a NIKON Eclipse 90i, and the software programs Nikon NIS-Elements and Image J were used for image analysis. γ-H2AX foci were quantified with Cell Profiler software and analyzed with IBM SPSS v.22, which was used to perform two-way ANOVA tests.

TUNEL assay {#s4-7}
-----------

Apoptosis was evaluated by TdT-mediated dUTP nick-end labeling (TUNEL) using the Dead-End Fluorometric TUNEL System (Promega, Madison, WI, USA), essentially as described by the manufacturer. Deparaffinized sections were postfixed using 4% PFA (pH 7.4) before and after treatment with proteinase K. Sections were incubated with the TdT enzyme for 1 hr and mounted with Vectashield mounting medium with DAPI before visualizing in a Nikon 90i microscope. TUNEL-positive cells were counted in the spiral ganglia in four serial paraffin sections per animal (prepared from at least three 4--5-month-old mice of each genotype) using Fiji software. Representative fluorescent stack images of the middle and basal cochlear turns were taken using a confocal microscope (LSM710 Zeiss, Oberkochen, Germany) with a glycerol-immersion objective (63x).

Organ of Corti dissection, cochleogram and hair cell quantification {#s4-8}
-------------------------------------------------------------------

The organ of Corti of decalcified cochleae was dissected into half-turns. The pieces were permeabilized with 1% Triton X-100 (Merck Millipore, Billerica, MA, USA), blocked with 5% normal goat serum (Sigma-Aldrich) and incubated overnight at 4°C with anti-MyoVIIA (rabbit, 1:250, PT-25--6790, Proteus, Ramona, CA, USA) or anti-neurofilament (mouse, 1:100, CBL212, Merck-Millipore). Alexa Fluor secondary antibodies or Alexa Fluor 647 Phalloidin (1:1000, A22287, Thermo Fisher Scientific, Waltham, MA, USA) were incubated at 1:200 for 2 hr at RT. The half-turns were then incubated with DAPI (1:1000, Thermo Fisher Scientific) and mounted with Prolong (Thermo Fisher Scientific), and low magnification fluorescent images were taken with Nikon 90i microscope. The cochleogram was plotted using a custom Fiji plugin as reported previously (plugin freely available at <http://www.masseyeandear.org/research/otolaryngology/investigators/laboratories/eaton-peabody-laboratories/epl-histology-resources/>). The numbers of inner (IHC) and outer (OHC) hair cells were counted using Fiji software in 200 μm sections in the apical, middle and basal regions, which are defined as grouped percentages of distance from apex (apical \<21%, middle 21--47%, basal \>47%). Segments were prepared from four mice of each genotype. Representative fluorescent stack images were taken at specified cochlear regions using a confocal microscope (LSM710 Zeiss, Oberkochen, Germany) with a glycerol-immersion objective (63x) and image spacing in the z plane of 0.7 μm.

RT-qPCR {#s4-9}
-------

Cochlear RNAs were extracted using an RNeasy kit (QIAGEN, Hilden, Germany) and the quality and quantity of these RNAs were determined using an Agilent Bioanalyzer 2100 (Agilent Technologies Santa Clara, CA, USA). RNA pools were made from at least three different animals from each age group and genotype. cDNA was then generated by reverse transcription (High Capacity cDNA Reverse Transcription Kit; Applied Biosystems, Foster City, CA, USA) and gene expression was analyzed in triplicate by qPCR on Applied Biosystems 7900 HT using TaqMan Gene Expression Assays (Applied Biosystems) for *Gpx1*, *Gpx4*, *Gsr*, *Gss*, *Gclc*, *Gclm*, *Cbs*, *Nox3*, *Nox4*, *Ucp1*, *Catalase*, *Cyba*, *Kim1*, *Apaf1, Il1b*, *Il6*, *Tnfa*, *Tgfb1*, *Il10*, *Foxp3*, *Mpz*, *RbFox3*, *Sox2* and *Prestin* ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). In addition, cDNAs were amplified in triplicate using gene-specific primers ([Supplementary file 3](#supp3){ref-type="supplementary-material"}) and Power SYBR Green PCR Master Mix (Applied Biosystems) to evaluate the expression of MAP kinase phosphatases. *Rplp0* or *Hprt1* were used as endogenous housekeeping control genes and the estimated gene expression was calculated as 2^--ΔΔCt^, as reported previously ([@bib83]).

Western blotting {#s4-10}
----------------

Cochlear proteins from 4-month-old mice (a pool of three cochleae of each genotype) were extracted using the extraction buffer of a Ready Protein Extraction Kit (Bio-Rad, Hercules, CA, USA) fsupplemented with 0.01% protease and 0.01% phosphatase inhibitors (Sigma-Aldrich).

Equal volumes of cochlear proteins were resolved using denaturing SDS-PAGE, followed by transfer to PVDF (Bio-Rad) membranes using Bio-Rad Trans Blot TURBO apparatus. Membranes were blocked using 5% BSA or non-fat dried milk in 0.075% Tween-TBS 1 mM and incubated overnight with the following antibodies: rabbit anti-P-p38 (1:1000, 9211, Cell Signaling, Danvers, MA, USA), rabbit anti-P-JNK (1:1000, 4668, Cell Signaling), rabbit anti-P-ERK (1:1000, 9101, Cell Signaling), rabbit anti-MKP1 (C-19) (1:1000, sc-370, Santa Cruz, Biotechnology), rabbit anti- γ-H2AX Ser^139^ (1:1000, 2577, Cell Signaling), rabbit anti-P22phox (1:250, sc-20781, Santa Cruz, Biotechnology, Dallas, TX, USA), rabbit anti-MnSOD (1:1000, 06--984, Merck-Millipore), rabbit anti-BAX (NT) (1:1000, ABC11, Merck-Millipore), and rabbit anti-PI3K (1:10,000). Immunoreactive bands were visualized using Clarity TM Western ECL Substrate (Bio-Rad) with an ImageQuant LAS4000 mini digital camera (GE Healthcare Bio-Sciences). Densities of the immunoreactive bands were quantified by densitometry using ImageQuant TL software.

Total protein extracts (WCE) were obtained from MEFs using the previously described lysis buffer ([@bib84]). Twenty micrograms of WCE per sample were loaded onto 10% SDS-PAGE polyacrylamide gels, and then transferred onto nitrocellulose membranes, or onto PVDF (Bio-Rad) membranes using Bio-Rad Trans Blot TURBO apparatus, followed by immunodetection using appropriate antibodies. Antibodies against the following proteins were: rabbit anti-MKP1 (C-19) (1;1000, sc-370, Santa Cruz, Biotechnology), rabbit anti P-p38 (1:2000, \#9211, Cell Signaling), rabbit anti-p38 (C-20) (1:1000, sc-535, Santa Cruz, Biotechnology), rabbit anti-caspase3 (1:1000, \#9662, Cell Signaling), mouse anti-β-actin (A5441, Sigma Aldrich) and mouse anti-β-tubulin as the loading control (T9026, Sigma Aldrich).

ROS levels {#s4-11}
----------

Cellular ROS levels were quantified by staining adherent cells with DHE followed by cell lifting with trypsin-EDTA and flow cytometric analysis. To quantify ROS by flow cytometry, adherent cells were stained with DHE for 45 min in PBS at 37°C in the dark. DHE is oxidizedto ethidium by superoxide in live cells ([@bib21]). Cells were lifted with trypsin-EDTA and washed, before fluorescence data were acquired within 60 min using the BD FACS Scan with a 488 nm laser and 585 nm DHE bandpass filters.

Quantification of DNA damage {#s4-12}
----------------------------

Cells were fixed in formaldehyde for 20 min, washed with PBS and permeabilized with Triton 0.5% for 10 min, before blocking with BSA 5% for 1 hr. Samples were incubated overnight with the primary antibody γ-H2AX Ser^139^ (Millipore) at 4°C, followed by a 1 hr incubation with the adequate secondary antibody at room temperature. DNA was stained with DAPI. Fluorescence microscopy was performed using a NIKON Eclipse 90i, and for the image analysis, the software program Nikon NIS-Elements and Image J were used. Secondary antibodies, conjugated with Alexa Fluor 488 (1:500), were purchased from Invitrogen. γ-H2AX foci were quantified with Cell Profiler software and analyzed using IBM SPSS 22 to perform two-way ANOVA tests.

Statistical analysis {#s4-13}
--------------------

Unless otherwise specified, data were analyzed by Student T-test after a Levene's or Fisher test of equality of variances with SPSS v23.0 software. Sample size was estimated to obtain a 90% statistical power with a 0.05 significance level, using data from previous experiments and calculating the Cohen\'s d value. Data are expressed as mean ± SEM. The results were considered significant at p\<0.05.
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10.7554/eLife.39159.018

###### Primers for RT-qPCR.

Primers for MKPs were designed using Primer Express 3.0 software and the mouse gene sequences available on the Ensembl genome database with references: NM_013642.3 (*Dusp1*), NM_010090.2 (*Dusp2*), NM_176933.4 (*Dusp4*), NM_001085390.1 (*Dusp5*), NM_026268.3 (*Dusp6*), NM_153459.4 (*Dusp7*), NM_008748.3 (*Dusp8*), NM_022019.6 (*Dusp10*) and NM_130447.3 (*Dusp16*). Base numbers indicate the location of the primer sequences in the corresponding mRNA; primers for *Dusp1* were designed in the region of exon 2.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: this article was originally rejected after discussions between the reviewers, but the authors were invited to resubmit after an appeal against the decision.\]

Thank you for submitting your work entitled \"Deficit of mitogen-activated protein kinase phosphatase 1 (MKP1) accelerates progressive hearing loss\" for consideration by *eLife*. Your article has been reviewed by a Senior Editor, a Reviewing Editor, and two reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: Sally Dawson (Reviewer \#2).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

Please accept our apologies for the long delay in the reviewing of your manuscript, due to the summer holidays. The reviewers found your work interesting, but raised several issues and concerns. It is not, therefore, possible to accept your manuscript for publication in its current state, and the changes required are deemed to be too extensive to be addressed within the window we normally allow for revisions. Should you wish to carry out these revisions and send a revised version of your paper to *eLife*, it will be treated as a new submission.

*Reviewer \#2:*

Celaya et al., present an analysis and characterisation of an auditory phenotype in a mouse model with targeted deletion of the MKP1 gene. Their extensive analysis includes expression analysis of MKP1 gene by RT-qPCR, evidence of auditory functional deficit by ABR and DPOAEs, and a quantitative assessment of hair cell and neuronal cellular loss in the cochlea which is correlated with the auditory deficit. Furthermore, they investigate the mechanism underlying the hearing loss and find some evidence for effects on reduced resistance to oxidative stress. I have very little in the way of criticism of what is included in the manuscript, which I find to be carried out well, clearly presented and proportionately discussed within the text.

My comments mainly refer to omissions from the manuscript that would improve the manuscript and relatively minor clarifications:

1\) No mention is made of the systematic effects of MKP1 deletion. What are these and could they have indirect on the auditory phenotype?

2\) The authors do not give an indication of whether there is a phenotype in the heterozygote mice and do not present any data from heterozygotes. This is disappointing; I would not expect a full characterisation of the heterozygous mice (hets) but it is important to know whether there is a hearing deficit in the hets. The authors suggest that MKP1 may play a role in general ARHL risk and pathogenesis and therefore this would be strengthened if 50% MKP1 also causes an auditory deficit. The manuscript would therefore be strengthened with addition of ABR data from hets.

3\) The approved name for this gene/protein is now DUSP1 which should be used within the manuscript, rather than MKP1.

4\) Figure 4, if available a lower zoom image of the wholemounts would provide an indication of base to apex gradient in hair cell loss.

5\) RT-qPCR data although it gives a quantitative assessment of cochlear gene expression it does not take into account the many cell types in the cochlea and an immunofluorescence characterisation of MKP1 and the oxidative stress genes would provide cell specific expression data. Have the authors attempted an immuno-characterisation of MKP1 expression?

6\) Could they clarify when SYBR green assays were used and when Taqman assays were used by giving Taqman assay IDs. Why were two different internal housekeeping gene assays used?

7\) It would be interesting to know whether these mice are at increased risk of noise induced hearing loss, although probably not required for publication.

8\) Although mostly well written there are some typos and grammatical errors particularly in the abstract which I suspect may have had some last minute changes, which were not proofread. ARHL is quite often mis-written as AHRL throughout manuscript.

9\) Discussion section, authors state \"oxidative stress as main cause of later problems\". Since they have not investigated any other mechanism then this is an over-statement.

*Reviewer \#3:*

The authors claimed that Mkp1 expression is age-regulated in the mouse cochlea and Mkp1 gene knock-out caused premature progressive hearing loss, suggesting that MKP1 is essential for cochlear homeostasis during ageing by regulating cochlear oxidative stress and inflammation.

The capability of MKP1 to regulate oxidative/inflammatory status in the cochlea is innovative and appealing topic. However, the principal limitation of the study is that the Authors omitted to describe/speculate on the molecular mechanism that link MKP1 deficiency with the increased oxidative stress/inflammation in the cochlea. Furthermore, there are a lot of criticisms that need to be carefully addressed.

Essential revisions:

1\) The criteria of inclusion of the animals in this study is not clear and this is a crucial point considering that the paper is focused on the age related hearing loss. Namely, it should be explained why the range of age for animal inclusion is wide: 2, 4-5, 8-9, 12 and 16-19 months of age. Considering the lifespan of this mice the differences of 2-3 months are relevant, especially in the old animals. Furthermore, the differences on the phenotype and the auditory function assessment should be illustrated for each group even if major data have been provided in 2-5-8 months of age group.

2\) Hearing function was assessed from 2 to 12 month-old and MKP1^-/-^ mice show ABR thresholds significantly higher with respect to controls (both for click and tone burst responses in almost all frequencies analyzed) already at 2 months of age; then, hearing function worsened with age compared to MKP1^+/+^ mice. It could be useful to assess hearing thresholds in an earlier time point, in order to demonstrate that MKP1^-/-^ mice show baseline threshold values similarly to controls and that hearing worsen with time compared to MKP1^+/+^ mice. This is relevant issue because the authors state that MKP1 deficiency accelerates the onset and the progression of age-related hearing loss. While, but, based on the current electrophysiological data, it is not clear if MKP1 deficiency also impairs the development of auditory function.

3\) It is not clear how DPOAE was recorded. In the Materials and methods section the authors refer to a previous published procedure (Martinez-Vega et al., 2015) but in this paper DPOAE recording was not performed. Also, OHC count reveals a marked decrease of cell number in the basal turn of MKP1^-/-^ mice, however DPOAE recording was performed by using primary tones for 8-14 kHz. Maybe, it could be useful to analyze also responses for higher frequencies. Also, it is not clear why DP level increased from 4-5 to 8-9 months, when the level of *Prestin* decreased (as shown in Figure 3B). I would expect a decrease of DPOAE responses in MKP1^-/-^ mice rather than an increase.

4\) The authors analyzed the level of genes involved in oxidative stress in cochlear samples from both genotypes and the ROS expression (DHE assay) was studied in MEF cells derived from MKP1^-/-^ and MKP1^+/+^ mice. Although the methodology was well conducted, in order to support the major conclusion that MKP1 is essential for the regulation of cochlear redox balance, it could be relevant to establish a direct relationship between cochlear oxidative stress and MKP1 activation in vivo. It could be helpful to perform some quantification (i.e. western blot analyses) on cochlear samples from MKP1^-/-^ and MKP1^+/+^ mice in order to correlate the modifications in cochlear redox status during aging in both genotypes with MKP1 level expression.

4\) Morphological observations have been performed only in 4-8 months old mice, however, ABRs revealed hearing loss also at 2 months of age in MKP1^-/-^ mice, thus morphological data at earlier time points could be added to support electrophysiological data.

6\) Figure 4: The quality of panels a-h could be ameliorated. Maybe fluorescence excitation was saturated, and this does not allow to appreciate the morphological details of the organ of Corti. Also, I suggest modifying DPOAE data presentation. Maybe it could be useful for data interpretation to graph DPOAEs in response to increasing stimulus intensity (showing 2f1-f2 dB SPL in y axis and f1 and f2 input level in the x axis), selecting only one representative frequency.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for choosing to send your work entitled \"Deficit of mitogen-activated protein kinase phosphatase 1 (MKP1) accelerates progressive hearing loss\" for consideration at *eLife*. Your letter of appeal has been considered by a Senior Editor, a Reviewing editor and two reviewers, and we are prepared to consider a revised submission with no guarantees of acceptance.

The reviewers differ in their opinions as to whether you will be able to perform the experiments required to provide new evidence concerning the role of MKP1 in the molecular mechanism and to demonstrate the link you propose between MKP1 and p38 activation, within the two months allowed. We are, however, willing to give you the opportunity to try to do this and advise you to pay close attention to the comments of reviewer 3.

Reviewer \#3:

Point 1:

In my opinion this criticism remains unsolved in absence of adjunctive experiments. The authors can improve the interpretation of results hypothesizing putative molecular mechanisms leading to activation of oxidative stress/inflammatory pathways, however, providing new evidence on the role of MKP1 molecular mechanism is challenging. The authors suggest a link between MKP1 and p38 activation that could be studied.

Point 2:

I am not in agreement with this experimental plan, because in my opinion, given the aging processes are one of the major topic of this study, more careful samples of animal age should be done. However, at least I suggest clarifying this point in the manuscript and to report this comment in Discussion section.

Point 3:

I suggest including data regarding ABR recordings at P31. However, considering that the authors state that at 2 months cell types are formed and there are no obvious morphological alterations or cytoarchitecture disorganization, even more so I think that they have to explain the threshold elevation observed in 2 months MKP1 KO animals with respect to Wt age-matched animals.

Point 4

I agree, these data have to be added to improve the study relevance.

Point 5

I agree, however, on the basis of these morphological data, as mentioned above, the Authors must to explain why the KO animals show a threshold elevation compared to WT controls at 2 months age. More details could be added.

10.7554/eLife.39159.024

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> Reviewer \#2:
>
> \[...\] My comments mainly refer to omissions from the manuscript that would improve the manuscript and relatively minor clarifications:

We appreciate very much the interesting comments and positive input by this reviewer.

> 1\) No mention is made of the systematic effects of MKP1 deletion. What are these and could they have indirect on the auditory phenotype?

In our experience, *Dusp1*mice are fertile and do not show higher mortality rates than wild types, or any other obvious general phenotypic trait.

Furthermore, *Dusp1*knock out mice have been studied and the general phenotype described in http://www.informatics.jax.org/allele/genoview/MGI:4940244?counter=4.

"Briefly, *Mkp1^-/-^* mice present an exacerbated inflammatory response in LPS-treated mice, with increased circulating levels of IL10, Il16 and TNF. *Mkp1^-/-^* mice are resistant to diet-induced obesity due to enhanced energy expenditure but succumb to glucose intolerance on a high fat diet. They present decreased body weight and decreased susceptibility to age-related obesity, accompanied by a smaller liver in aged mice. Mitochondria of their skeletal muscles exhibit increased respiration. *Mkp1^-/-^* mice are also resistant to stress-induced anhedonia (Dorfman et al., 1996; Hammer et al., 2006; Salojin et al., 2006; Shen et al., 2016; Shi et al., 2010)".

Up to our knowledge, there are not previous studies focused on ARHL.

The revised article we have includes under the Matherial and Methods section a reference to the aforementioned general phenotype of the null *Dusp1* mice described in www.informatics.jax.org.

> 2\) The authors do not give an indication of whether there is a phenotype in the heterozygote mice and do not present any data from heterozygotes. This is disappointing; I would not expect a full characterisation of the heterozygous mice (hets) but it is important to know whether there is a hearing deficit in the hets. The authors suggest that MKP1 may play a role in general ARHL risk and pathogenesis and therefore this would be strengthened if 50% MKP1 also causes an auditory deficit. The manuscript would therefore be strengthened with addition of ABR data from hets.

The comment is right and indeed we have studied the heterozygous mice and we could have mentioned the data in the original manuscript, however it was already very long and included much information and we decided not to. The heterozygous phenotype observed is presented in [Author response image 1](#respfig1){ref-type="fig"} (pale grey dots) and compared with that of wild type and KO mice. Hearing evolution was followed up in a longitudinal experiment up to the age of 9 months. There were no differences in ABR thresholds and, therefore, we discontinued the experiment. These results can be explained by the presence and upregulation of other family members, among other hypothesis.

![Comparative longitudinal hearing evaluation of *Dusp1^+/+^, Dusp1^+/-^*and *Dusp1^-/-^*mice.\
Evolution of ABR thresholds (mean ± SEM) in response to click and tone bursts stimuli in *Dusp1^+/+^*(white circles), *Dusp1^+/-^*(grey circles) and *Dusp1^-/-^*(black circles) mice of 2 (*Dusp1^+/+^,* n=10; *Dusp1^+/-^*, n=7; *Dusp1^-/-^*, n=7), 4-5 (*Dusp1^+/+^,* n=28; *Dusp1^+/-^*, n=7; *Dusp1^-/-^*, n=24), 8-9 months of age (*Dusp1^++/+^,* n=24; *Dusp1^+/-^*, n=6; *Dusp1^-/-^*, n=22) and 12 months of age (*Dusp1^+/+^,* n=7; *Dusp1^+/-^*, n=3). Statistically significant differences were analysed by Student's t-test comparing genotypes, \* *Dusp1^+/-^*vs. *Dusp1^+/+^; \^ Dusp1^+/-^*vs. *Dusp1^-/-^* (\*,\^p\<0.05, \*\*,\^\^p\<0.01, \*\*\*,\^\^\^p\<0.001).](elife-39159-resp-fig1){#respfig1}

The revised article mentions the auditory phenotype of the heterozygous mouse in the Results section as data not shown, since no differences were found in comparison with wild type mice.

> 3\) The approved name for this gene/protein is now DUSP1 which should be used within the manuscript, rather than MKP1.

In the revised manuscript we use the HGNC nomenclature.

> 4\) Figure 4, if available a lower zoom image of the wholemounts would provide an indication of base to apex gradient in hair cell loss.

The lower zoom images have been taken and will be included in the revised version of the manuscript. Revised Figure 4 has been modified as suggested and microphotographs are presented showing the complete width as they were captured.

> 5\) The RT-qPCR data, although it gives a quantitative assessment of cochlear gene expression, does not take into account the many cell types in the cochlea and an immunofluorescence characterisation of MKP1 and the oxidative stress genes would provide cell specific expression data. Have the authors attempted an immuno-characterisation of MKP1 expression?

The reviewers comment is highly relevant and we should have described better the available data in the literature. MKP1 is a transitory inducible gene (Gass et al., 1996). Thus, we discarded the approach of detecting the protein by immunohistochemistry and this is the reason why expression is shown in the cellular model. The *Mkp1/Dusp1* mRNA expression has been already reported and is available at several Internet repositories; therefore, we decided to reduce the number of mice in the study. Concretely, available data support our results and its expression is low during development (https://www.ensembl.org/Mus_musculus/Gene/ExpressionAtlas?g=ENSMUSG00000024190; r=17:26505590-26508519) in almost all tissues but liver and intestine. RNAseq studies of the organ of Corti available at (gEAR portal of visualization of multi-omic data https://umgear.org/) indicate that it is expressed in the cochlea and vestibule and that expression is enriched in supporting cells. Furthermore, noise has been reported to induce its expression (Alagramam et al., 2014; Kirkegaard et al., 2006). In this connection, we have designed further experiments that will be included in the revised version of the manuscript if we are granted this opportunity.

For the resubmission of the article, we have confirmed the presence of DUSP1 protein in the cochlea by inducing its expresión with noise as already reported (Alagramam et al., 2014; Kirkegaard et al., 2006). Information regarding other studies mentioned above, which indicate its presence in supporting cells in the cochlea and vestibule, has been referenced in the Discussion section.

> 6\) Could they clarify when SYBR green assays were used and when Taqman assays were used by giving Taqman assay IDs. Why were two different internal housekeeping gene assays used?

The SYBR green assays were specified in Table 1 in the manuscript and the IDs of the TaqMan probes will be provided in the revised one. We typically use two housekeeping genes in RTqPCR gene expression experiments and, then, normally *Rplp0* as reference for further calculations. However, in the longitudinal study we observed that the most stable gene expression pattern along time was that of *Hprt1* and therefore it was used in these experiments as reference gene. We can specify this further in the manuscript or, if this possesses a problem, we have the data with both housekeeping genes for all the experiments performed and we can recalculate.

The revised version of the article includes supplementary tables have been prepared specifying the ID of the TaqMan probes and SYBR green assays and are referenced in the Methods section (Supplementary file 2 and Supplementary file 3).

> 7\) It would be interesting to know whether these mice are at increased risk of noise induced hearing loss, although probably not required for publication.

We totally agree with this view, and indeed this was planned. The revised article includes experiments addressing noise exposure of *Dusp1* null mice in a new figure (Figure 7).

> 8\) Although mostly well written there are some typos and grammatical errors particularly in the abstract, which I suspect may have had some last minute changes, which were not proofread. ARHL is quite often mis-written as AHRL throughout manuscript.

Typos have been corrected and the Abstract revised.

> 9\) Discussion section, authors state \"oxidative stress as main cause of later problems\". Since they have not investigated any other mechanism then this is an over-statement.

The sentence has been rewritten to \"oxidative stress is one of the possible causes of later problems" to accommodate the fact that we have not investigated any other mechanism.

> Reviewer \#3:
>
> \[...\] The capability of MKP1 to regulate oxidative/inflammatory status in the cochlea is innovative and appealing topic. However, the principal limitation of the study is that the authors omitted to describe/speculate on the molecular mechanism that link MKP1 deficiency with the increased oxidative stress/inflammation in the cochlea.

We agree with the reviewers' concern, although in our opinion, this goes beyond the main message of this manuscript and could be another complete issue, but we agree that is highly recommended to discuss the molecular mechanism involved in the process of hearing loss.

Furthermore, our data encouraged us to explore the molecular mechanism underlying apoptosis induction in cochlea cells. Some speculations could be done based on what it has been reported in other cellular contexts, (Wang et al., 2007; Zhang et al., 2012). First, we hypothesized that inflammatory cytokines could be responsible to generate a retro-alimentation loop. We are addressing this point in vitro, and our data suggest that the absence of MKP1 exacerbate the p38 activation in response to cytokines and, consequently, enhance apoptosis through caspase 3 activation.

> Essential revisions:
>
> 1\) The criteria of inclusion of the animals in this study is not clear and this is a crucial point considering that the paper is focused on the age related hearing loss. Namely, it should be explained why the range of age for animal inclusion is wide: 2, 4-5, 8-9, 12 and 16-19 months of age. Considering the lifespan of this mice the differences of 2-3 months are relevant, especially in the old animals. Furthermore, the differences on the phenotype and the auditory function assessment should be illustrated for each group even if major data have been provided in 2-5-8 months of age group.

We understand the reviewers concern and this will be clarified in the reviewed manuscript. We have measured ABR threshold monthly in several cohorts, an example is provided in [Author response image 2](#respfig2){ref-type="fig"}. Taking into account this parameter, ABR data were grouped afterwards to reduce the number of animals used in further experiments, and also to avoid including redundant information in the manuscript. Certain cohorts were used to obtain specific time points for further analysis. ABR measurements were carried out until knock out mice were profoundly deaf (ABR threshold \>90-100 dB SPL). Twelve month-old knock out mice did not show increased mortality rates when compared with wild types, although this was the age-group with the lowest n of those studied here and we will not risk conclusions. A few wild type mice were kept, to know at which age this genotype show profound deafness, therefore we could observe that wild type mice mortality rate increased from 18 months of age on.

![Monthly evolution of auditory thresholds.](elife-39159-resp-fig2){#respfig2}

> 2\) Hearing function was assessed from 2 to 12 month-old and MKP1^-/-^ mice show ABR thresholds significantly higher with respect to controls (both for click and tone burst responses in almost all frequencies analyzed) already at 2 months of age; then, hearing function worsened with age compared to MKP1^+/+^ mice. It could be useful to assess hearing thresholds in an earlier time point, in order to demonstrate that MKP1^-/-^ mice show baseline threshold values similarly to controls and that hearing worsen with time compared to MKP1^+/+^ mice. This is relevant issue because the authors state that MKP1 deficiency accelerates the onset and the progression of age-related hearing loss. While, but, based on the current electrophysiological data, it is not clear if MKP1 deficiency also impairs the development of auditory function.

The recommended age to perform ABR is two months; however, we will take earlier time points (ongoing experiments) to confirm if there are differences between genotypes in one-month old mice. The reviewer is correct that a subtle deficiency seems to be there, however all cell types are formed and there are no obvious morphological alterations or cytoarchitecture disorganization. On the other hand, available data suggest a very low expression during development (see above answer to Q5 from reviewer 2).

> 3\) It is not clear how DPOAE was recorded. In the Materials and methods section the authors refer to a previous published procedure (Martinez-Vega et al., 2015) but in this paper DPOAE recording was not performed. Also, OHC count reveals a marked decrease of cell number in the basal turn of MKP1^-/-^ mice, however DPOAE recording was performed by using primary tones for 8-14 kHz. Maybe, it could be useful to analyze also responses for higher frequencies. Also, it is not clear why DP level increased from 4-5 to 8-9 months, when the level of Prestin decreased (as shown in Figure 3B). I would expect a decrease of DPOAE responses in MKP1^-/-^ mice rather than an increase.

The reviewer is right, and the reference was mistaken, the DPOE method was reported in a Martínez-Vega 2015 manuscript entitled "Long-term omega-3 fatty acid supplementation prevents expression changes in cochlear homocysteine metabolism and ameliorates progressive hearing loss in C57BL/6J mice" (Martinez-Vega et al., 2015). The requested DPAOE measurements at higher frequencies will be done. The parameter represented in Figure 3B is DPOAE thresholds, therefore numbers should indeed increase in parallel with the reported loss of OHC. This will be better explained in the revised version of the manuscript to avoid confusions.

> No problem. The revised manuscript contains the DPOAE presented as suggested and the correct reference.
>
> 4\) The authors analyzed the level of genes involved in oxidative stress in cochlear samples from both genotypes and the ROS expression (DHE assay) was studied in MEF cells derived from MKP1^-/-^ and MKP1^+/+^ mice. Although the methodology was well conducted, in order to support the major conclusion that MKP1 is essential for the regulation of cochlear redox balance, it could be relevant to establish a direct relationship between cochlear oxidative stress and MKP1 activation in vivo. It could be helpful to perform some quantification (i.e. western blot analyses) on cochlear samples from MKP1^-/-^ and MKP1^+/+^ mice in order to correlate the modifications in cochlear redox status during aging in both genotypes with MKP1 level expression.

Experiments are ongoing to further evaluate cochlear oxidative stress at the protein level.

> 5\) Morphological observations have been performed only in 4-8 months old mice, however, ABRs revealed hearing loss also at 2 months of age in MKP1^-/-^ mice, thus morphological data at earlier time points could be added to support electrophysiological data.

Histological analysis was performed at several ages in both genotypes, although they were not included in the original manuscript. As an example, please see Figure 3---figure supplement 2.

> Please, I believe that this criticism is relevant and should be explained.
>
> 6\) Figure 4: The quality of panels a-h could be ameliorated. Maybe fluorescence excitation was saturated, and this does not allow to appreciate the morphological details of the organ of Corti. Also, I suggest modifying DPOAE data presentation. Maybe it could be useful for data interpretation to graph DPOAEs in response to increasing stimulus intensity (showing 2f1-f2 dB SPL in y axis and f1 and f2 input level in the x axis), selecting only one representative frequency.

We agree with these comments, both microphotographs and data have been obtained, and all suggestions will be incorporated in the revised version of the manuscript.

We have improved the quality of a-h panels and added the DPOAE representation as suggested by the reviewer.

\[Editors' note: the author responses to the second round of peer review follow.\]

> Point 1:
>
> In my opinion this criticism remains unsolved in absence of adjunctive experiments. The authors can improve the interpretation of results hypothesizing putative molecular mechanisms leading to activation of oxidative stress/inflammatory pathways, however, providing new evidence on the role of MKP1 molecular mechanism is challenging. The authors suggest a link between MKP1 and p38 activation that could be studied.

Following the reviewers´ suggestion, the revised manuscript includes experiments showing that: (i) DUSP1 absence increases oxidative stress, inflammation and apoptosis in vivo by using a combination of RT-qPCR, western blotting and immunohistochemistry experiments; and (ii) one of the cytokines induced in vivo, TNFα, has been used in cultured MEFs from the null mouse to show that it strongly activates p38 in DUSP1 absence. Furthermore, only in this condition, we observed the activation of caspase 3 that clearly indicated apoptosis program activation. This data has been included in Figure 6---figure supplement 1. All these results taken together reinforce our previous putative models and in addition a putative molecular mechanism leading to activation of oxidative stress is discussed in the revised manuscript.

> Point 2:
>
> I am not in agreement with this experimental plan, because in my opinion, given the aging processes are one of the major topic of this study, more careful samples of animal age should be done. However, at least I suggest clarifying this point in the manuscript and to report this comment in Discussion section.

A clarification regarding the grouping of animals has been added to the Materials and methods section and data showing the monthly evolution of auditory thresholds presented above have been included in the manuscript under the Results section (Supplementary file 1).

> Point 3:
>
> I suggest including data regarding ABR recordings at P31. However, considering that the authors state that at 2 months cell types are formed and there are no obvious morphological alterations or cytoarchitecture disorganization, even more so I think that they have to explain the threshold elevation observed in 2 months MKP1 KO animals with respect to Wt age-matched animals.

As suggested by the reviewer, we performed ABR analysis in one-month old mice, no differences were found between genotypes except on the click and 40 kHz stimuli, with an increase of about 8 dB in knock out mice. Data from one-month-old mice has been added to the revised manuscript in a new table (Supplementary file 1).

> Point 4
>
> I agree, these data have to be added to improve the study relevance.

For the resubmission of the manuscript we have performed noise exposure experiments that link the activation of DUSP1 to this damaging stimulus, which induces oxidative stress and inflammation. Furthermore, we have performed new experiments that strenghten the link between the absence of DUSP1 and the increase in oxidative stress. We have observed by inmunochemistry that null mice show increased levels of nytrotirosine, a product of tyrosine nitration mediated by reactive nitrogen species, at the age of two months (Figure 5---figure supplement 1) and have confirmed by western blotting an increase in the levels of p22phox in 5-month-old null mice. Finally, in the Discussion section, we discuss a putative molecular mechanisms linking DUSP1 to the increase of oxidative stress based on data available in the literature.

> Point 5
>
> I agree, however, on the basis of these morphological data, as mentioned above, the Authors must to explain why the KO animals show a threshold elevation compared to WT controls at 2 months age. More details could be added.

The reviewer is correct that the difference between genotypes at this young age might be a clue to understand the progressive phenotype. One-month-old mice do not present apparent differences in auditory phenotype, and the 2 month-old histology corroborates the presence of all cell types with no obvious morphological alterations. However, gene expression experiments suggested that a redox unbalance was present at this early age, suggesting that molecular alterations precede the cellular loss phenotype. To asses this hypotheses, we have tested the levels of protein tyrosine nitration caused by increased reactive nitrogen species, indeed the null mouse shows increased 3-NT levels and these data have been included in a new figure of the revised version of the manuscript and further discussed in the text.

[^1]: These authors contributed equally to this work.
